Migraine pathophysiology: the nutritional angles
Migraine is a complex neurological disorder affecting approximately 12% of the population, with a 3:1 female predominance. The pathophysiology involves:
- Cortical spreading depression (CSD) — a wave of neuronal and glial depolarisation that propagates at 3–5 mm/min
- Trigeminovascular activation — release of CGRP and substance P causing neurogenic inflammation in meningeal blood vessels
- Mitochondrial dysfunction — particularly relevant in migraine with aura; mitochondrial energy deficit lowers the CSD threshold
- Neuroinflammation — NF-κB and inflammatory cytokines are activated during and between attacks in chronic migraine
Magnesium: the most established nutritional link
Magnesium deficiency is found in approximately 50% of migraine patients during acute attacks (lower cerebrospinal fluid magnesium). The mechanisms:
- Magnesium inhibits NMDA receptors — low magnesium increases neuronal excitability and lowers the CSD threshold
- Magnesium stabilises mitochondrial function — preventing the energy deficit that triggers attacks
- Magnesium modulates serotonin receptors and platelet aggregation — both relevant to migraine trigger pathways
Multiple RCTs show oral magnesium supplementation (400–600 mg/day) reduces migraine frequency by approximately 40% in deficient patients. The effect is specific to magnesium-deficient individuals — those with normal magnesium see minimal benefit.
Spirulina provides approximately 35–40 mg magnesium per 10 g — 8–10% of the daily requirement. This is a meaningful contribution to maintaining magnesium adequacy, not a therapeutic supplement dose. For established migraine management, dedicated magnesium glycinate or citrate at 300–500 mg elemental magnesium/day is the evidence-based intervention; spirulina is a useful dietary top-up.
Riboflavin (B2): mitochondrial energy support
Riboflavin is a cofactor for flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) — critical for the mitochondrial electron transport chain. In migraine patients, mitochondrial complex I and II activity is often reduced; riboflavin supplementation improves mitochondrial efficiency.
A Cochrane-reviewed trial (400 mg/day riboflavin for 3 months) showed a 50% reduction in migraine attack frequency. This high-dose effect requires dedicated B2 supplementation — spirulina provides approximately 0.3–0.4 mg riboflavin per 5 g (23–31% of the 1.3 mg daily requirement). While meaningful for general riboflavin adequacy, spirulina cannot replicate the 400 mg therapeutic dose.
Phycocyanin and neuroinflammation
During migraine attacks, NF-κB is activated in trigeminal ganglia and central sensitisation develops. Phycocyanin inhibits NF-κB and CGRP-stimulated inflammatory signalling in neuronal cell lines. In animal models, phycocyanin reduces neuroinflammation markers including CGRP expression and COX-2 activity in relevant neural tissues.
No human migraine trial for spirulina exists. The mechanistic alignment is specific and coherent — but clinical evidence is absent.
Iron and migraine: an underappreciated link
Iron deficiency is significantly more prevalent in chronic migraine patients than in matched controls. Iron is required for serotonin synthesis (as a cofactor for tryptophan hydroxylase) and for dopamine metabolism. Low serotonin is a classic migraine trigger.
Women with menstrual migraine — particularly those with perimenstrual attacks associated with their cycle — have a higher prevalence of iron deficiency. Spirulina’s iron is directly relevant to this subgroup.
Practical guidance
- Test magnesium and ferritin first:Red blood cell magnesium (more accurate than serum) and ferritin. Deficiency in either warrants specific supplementation, not just spirulina.
- For magnesium deficiency:Magnesium glycinate 300–400 mg/day elemental magnesium is the therapeutic form. Spirulina’s 35–40 mg/10 g contributes but does not substitute.
- For riboflavin-specific migraine prevention:Dedicated 400 mg/day B2 is the evidence-based approach. Spirulina contributes food-matrix B2 to overall adequacy.
- Spirulina role: Background nutritional support — ensuring magnesium, riboflavin, and iron adequacy that removes the nutritional contributors to migraine threshold lowering. Not an acute treatment or standalone preventive.
What spirulina does not do for migraines
- Provides acute relief during an attack — there is no mechanism for this
- Replaces triptans or CGRP antagonists for acute treatment
- Matches the therapeutic doses of magnesium or riboflavin used in clinical trials